About this site

Thanks for visiting our site!

This site uses a social networking platform to bring information and social networking features to the community. You can sign-up, join groups, subscribe to information, and make friends. Once you sign in you can check your activity stream to see what is happening across the site and contribute your thoughts and experiences.

Recent Posts

June 14
Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities
A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor...
read more
June 10
Novel Therapy Shows Promise in Group of Patients with Metastatic Colon Cancer
Patients with HER2-expressing metastatic colorectal cancer appeared to achieve durable and promising...
read more
June 10
Provectus Biopharmaceuticals Announces Publication of In Vitro Data from Research on Oral Delivery of PV-10® at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
KNOXVILLE, TN, June 09, 2021 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that...
read more
June 10
Advarra expands Gene Therapy Ready network with 500+ sites
June 9, 2021 -- Advarra's Gene Therapy Ready network has grown to over 500 registered research...
read more
June 10
Old antidepressants show promise as immuno-oncology treatments in melanoma and colon cancer
A class of antidepressants known as monoamine oxidase inhibitors (MAOIs) first hit the market in the...
read more